Folic acid linkers, often incorporating PEG spacers, are designed to target folate receptors that are overexpressed on certain cells, particularly in cancer and inflammatory diseases. By leveraging the high-affinity binding between folic acid and folate receptors, these linkers enable selective delivery of drugs, imaging agents, or other bioactive molecules to receptor-positive cells, improving targeting precision and reducing off-target effects.